Vizgen
Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.
6
Funding Rounds
$255.4m
Money raised
Funding
Funding series
Funding Series Analysis
The company Vizgen has raised a total of $204.4m in funding over 6 rounds.
Key Insights:
- Vizgen, Inc. Series C round, June 2022: $85.2m
- Vizgen, Inc. Funding Round, April 2022: $105.2m
- Vizgen, Inc. Series A round, January 2020: $14m
- Vizgen, Inc. funding round, October 2019: $14m
- Vizgen, Inc. funding round, April 2021: $37m
Vizgen, Inc. Series C round, June 2022
$85.2m
Vizgen, Inc. Funding Round, April 2022
$105.2m
Vizgen, Inc. Series A round, January 2020
$14m
Vizgen, Inc. funding round, October 2019
$14m
Vizgen, Inc. funding round, April 2021
$37m
Industries
Vizgen is active in the following industries:
- Biomedical engineering
- Diagnosis
- Engineering
- Technology
- Biology
- Biotechnology
- Genomics